2020 Virology & Bacteriology Industry Insights - The Threat of Bioterrorism is Among the Main Driving Forces

DUBLIN, March 25, 2020 /PRNewswire/ -- The "2020 World Virology and Bacteriology Market for over 100 Tests: Americas, EMEA, APAC - A 68-Country Analysis - Supplier Shares & Strategies, Test Volume & Sales Segment Forecasts, Emerging Technologies, Instrumentation, Opportunities" report has been added to ResearchAndMarkets.com's offering.


This unique 68-country survey provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The report provides granular market segmentation analysis and forecasts for over 100 microbiology tests; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and strategies for suppliers.


This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world's major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Geographic Regions

Asia-Pacific, Europe, Latin America, Middle East, North America

Country Analyses

Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Myanmar, Netherlands, New Zealand, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, UK, United Arab Emirates, USA, Venezuela, Vietnam.

Market Segmentation Analysis

    --  Sales and market shares of major suppliers of infectious disease
        diagnostic products in major countries by test.
    --  Test and sales forecasts for 100 infectious disease diagnostic assays by
        country, individual test and market segment:
    --  Review of market dynamics, trends, structure, size, growth and major

Current & Emerging Products

    --  In-depth examination of major diseases, including their etiology,
        current diagnostic tests, vaccines, drugs and market needs.
    --  Review of major analyzers used for infectious disease testing, including
        their operating characteristics, features and selling prices.

Technology Review

    --  Assessment of emerging diagnostic technologies and their potential
        applications for infectious disease testing.
    --  Companies developing or marketing infectious disease diagnostic products
        by individual test.

Competitive Assessments

    --  Strategic assessments of major suppliers and emerging market entrants,
        including their sales, product portfolios, marketing tactics,
        collaborative arrangements and new products in R&D.

Opportunities and Strategies for Suppliers

    --  Emerging opportunities for new instrumentation, reagent systems, IT and
        other products with significant market appeal during the next five
    --  Design criteria for decentralized testing products.
    --  Alternative market penetration strategies.
    --  Potential market entry barriers and risks.

Companies Mentioned

    --  Abbott
    --  Affymetrix
    --  Beckman Coulter/Danaher
    --  Becton Dickinson
    --  bioMerieux
    --  Bio-Rad
    --  Cepheid
    --  Diamedix
    --  DiaSorin
    --  Eiken Chemical
    --  Elitech Group
    --  Enzo Biochem
    --  Fujirebio
    --  Grifols
    --  GSK Biologicals
    --  Hologic
    --  Leica Biosystems
    --  Lonza
    --  Ortho-Clinical Diagnostics
    --  PerkinElmer
    --  Qiagen
    --  Roche
    --  Scienion
    --  Sequenom
    --  SeraCare
    --  Siemens Healthineers
    --  Takara Bio
    --  Thermo Fisher
    --  Wako

*Contains 2,300 pages and 947 tables.

For more information about this report visit https://www.researchandmarkets.com/r/umuxi3

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/2020-virology--bacteriology-industry-insights---the-threat-of-bioterrorism-is-among-the-main-driving-forces-301029628.html

SOURCE Research and Markets